The Impact of Migraine on the Whole Life Course of Patients: Results from the OVERCOME (Japan) 2nd Study

Daisuke Danno(Tominaga hospital), Mika Komori(Eli Lilly (Japan)), Yoshinori Tanizawa(Eli Lilly (Japan)), Satoshi Osaga(Eli Lilly (Japan)), Ryotaro Ishii(Kyoto Prefectural University of Medicine), Tsubasa Takizawa(Keio University), Shiho Suzuki(Dokkyo Medical University), Masayuki Hamakawa
Neurology and Therapy
December 21, 2024
Cited by 7


Related Papers